Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food-producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2012-13, the industry accounted for just 4.5% of the overall pharmaceutical sector.
Over the five years through 2014-15, the performance of the industry has been highly volatile, as it has contended with a number of external shocks... purchase to read more
Industry Report - Industry Key Buyers Chapter
Echoing the unprecedented degree of change currently occurring within the general pharmaceutical sector, the competitive landscape of the Veterinary Pharmaceutical Manufacturing industry has undergone significant change in the five years through 2014-15. Consolidation pressures continue to characterise the industry, and this has had implications for market share concentration trends.
Following Pfizer's 2009 acquisition of Wyeth Corporation and its subsidiary Fort Dodge Animal Health, the industry underwent a significant shake up. Fort Dodge's assets were split in Australia between Pfizer and Virbac, both already major players. This resulted in increased industry concentration... purchase to read more